Abstract

Using the Get With the Guidelines-Stroke registry, Mendelson et al.1 showed that 3.7% of patients with acute ischemic stroke decline intravenous tissue plasminogen activator (tPA), despite being eligible. The authors found significant racial differences in the tPA declination rates. Compared with non-Hispanic White patients, non-Hispanic Black patients were 21% more likely to decline tPA and Asian patients were 28% less likely.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call